Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JG.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.27.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ED.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
S.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.215EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBNEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.147EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.6 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.5 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.4 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.71 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.33.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.465EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.2.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XFEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used